Table 4.

Adverse events in the ITT influenza-infected population

		mPOCT group (n=100)	Control group (n=102)	Relative risk (95% CI)	p value
Total number of adverse events		19	34	..	..
Patients with adverse events		16 (16%)	23 (23%)	0·7 (0·4–1·3)	0·24
ICU or HDU admission		1 (10%)*	6 (6%)†	0·2 (0·0–1·1)	0·058
Death
	In hospital	0	2 (2%)‡	NA	0·16
	Within 30 days	0	2 (2%)‡	NA	0·16
Readmission within 30 days		6 (6%)	5 (5%)	1·2 (0·4–3·8)	0·76
Re-presentation to hospital but without admission, within 30 days		2 (2%)	1 (1%)	2·0 (0·2–21·7)	0·56
Hospital stay of >7 days		10 (10%)	20 (20%)	0·5 (0·3–1·0)	0·055

Data are n or n (%) unless otherwise stated. p values for the difference between proportions were calculated using the χ² or Fisher's exact test as appropriate, and for continuous variables (ie, difference in medians) using the Mann-Whitney U test. HDU=high dependency unit. ICU=intensive care unit. ITT=intention-to-treat. mPOCT=molecular point-of-care test. NA=not applicable.

^*Influenza A H3.

^†Influenza A H3 n=2, influenza A H1 n=1, influenza A untypable n=1, and influenza B n=2.

^‡Influenza B n=1 and influenza A untypable n=1.